Vanguard crLyme helps provide broad spectrum coverage against outer surface protein A (OspA), found in the tick, and contains antigens from multiple types of outer surface protein C (OspC), found in the tick and dog.
Indication: For vaccination of healthy dogs 8 weeks of age or older as an aid in prevention of clinical disease and subclinical arthritis associated with Borrelia burgdorferi.
The first Lyme disease vaccine for dogs to contain a recombinant OspC protein
Demonstrated efficacy in helping prevent Lyme infection
Excellent performance in a field safety study
Covered by Companion Animal Immunization Support Guarantee (ISG)
Revision date indicates the date the MSDS or SDS was last revised. MSDS / SDS are
dated when they are originally issued AND when any significant change has been made
to the chemical compound or research has revealed a health or physical hazard different
from what was originally stated.